At the single center with 20 years followup, the 35 patients followed had weight loss of 30.1 kg, 48.9% EWL and 22.2% total weight loss
This can be particularly detrimental when using semaglutide, as it is designed to help regulate your appetite and blood sugar levels
GLP-1 Semaglutide Studied for weight management in appropriate patients
Fogari R, Derosa G, Zoppi A, Rinaldi A, Lazzari P, Fogari E, et al
Tirzepatide Research Guide: Mechanism, Dosage Reference & Studies A complete Australia research reference for tirzepatide dual GIP/GLP-1 receptor agonism, published study data, and analytical documentation expectations
Many practitioners use 8 to 12 weeks on followed by 4 weeks off for growth-hormone-focused stacks, while metabolic agents like GLP-1 analogues are often tapered under medical supervision rather than cycled abruptly